Momentum Stocks

CSW Industrials Reaches Deal With Shareholder Newtyn on Director Nominees

CSW Industrials said it has secured support from shareholder Newtyn Management LLC and affiliates for the company’s director nominee Michael Gambrell. Under the agreement, Newtyn will participate in the development of the position profile of one of the two new directors that are expected to be appointed in the candidate[Read More…]

by July 18, 2016

T2 Biosystems Edges Up on Research Collaboration

T2 Biosystems shares were 2.9% higher Monday morning after the company said that it has entered into a multi-year agreement to provide its T2 Magnetic Resonance technology platform (T2MR) for Bayer’s research and development program for blood coagulation disorders. The collaboration will develop tools and evaluate assays to help drive[Read More…]

by July 18, 2016

Cabela’s To Open New Stores

Cabela’s Inc, a specialty retailer and a direct marketer of hunting, fishing, camping and related outdoor merchandise, said Thursday that it plans on expanding its retail footprint to two new locations: Albuquerque, New Mexico., and Chesterfield Township, Michigan. The company expects to begin the construction of the 70,000-square-foot store in[Read More…]

by July 14, 2016

Immunomedics Shares Down 16%; ASCO Won’t Let Company Present ‘Old’ Data on Drug

Immunomedics (IMMU) shares fell 16% in pre-market trade after The Street cited the American Society of Clinical Oncology as saying it has removed the company’s presentation of the breast cancer drug IMMU-132 from the press program. The report cited program coordinator in ASCO’s science communications department Alise Fisher as saying[Read More…]

by June 3, 2016

J.P.Morgan Upgrades Rating on Celgene Corporation (NASDAQ:CELG) from Neutral to Overweight. Here is Why

Biotechnology Equity Analysts Cory Kasimov AC, Brittany Terner, Whitney G Ijem and Morgan T Haller of Investment House J.P.Morgan upgraded their rating on Celgene Corporation (NASDAQ:CELG) from Neutral to Overweight and slapped a $152 price target on the stock. According to the report ”We are upgrading CELG to Overweight from[Read More…]

by October 1, 2015